Registry for Bone Metastases
ConditionBone Metastases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a specific diagnosis or condition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥22 years
Biopsy-proven or clinically obvious metastatic bone disease . For purposes of this study, metastatic bone disease includes skeletal involvement from multiple myeloma.
Symptomatic bone lesion requiring intervention
This includes but is not limited to radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above
Disqualifiers
Age <22 years
Trial population
There is also a retrospective component to this study, in which we will review data on patients going back to 2015; we will analyze data from any patients who died with symptomatic metastatic bone disease for possible inclusion in the IBMR. Living patients will be prospectively enrolled into the trial. For the retrospective component, only deceased patients (500) will be analyzed.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 1 trial groupGroup A: Bone Metastases
Trial outcomes
Primary outcomes
1
overall survival
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov